Decreased incidence of neuroblastomas in Down's syndrome and overproduction of S-100 B protein

Medical Hypotheses

Volumn 46, Issue 4, 1996, Pages 393-399

  Satge, D ^a  

^a CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN S 100;

DOWN SYNDROME; HUMAN; HYPOTHESIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0029962196     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90193-0     Document Type: Article

References (47)

1. Narod S A, Stiller C, Lenoir G M. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991; 63: 993-999.
2. Satge D, Sommelet D, Geneix A, Malet P, Vekemans M. Tumoral profile in Down syndrome: a step towards the understanding of the consequences of aneuploidy and the development of cancer. Am J Hum Genet 1994; 55 supp A 303 No 1777.
3. McWilliams N B. Neuroblastoma in infancy. Associated conditions. In: Pocheldy C, ed. Neuroblastoma: Tumor Biology and Therapy. Boston, MA: CRC Press, 1990: 232.
4. Woods W G, Lemieux B, Tuchman M. Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec neuroblastoma screening project. Pediatrics 1992; 89: 114-118.
5. Miller R W. Childhood cancer and congenital defects. A study of US death certificates during the period 1960-1966. Pediat Res 1969; 3: 389-397.
6. Hosot H, Sawada T, Nakajima T et al. A case of mosaic Down's syndrome concomitant with ganglioneuroma. J Pediat Surg 1989; 24: 210-211.
7. Miller R W, Fraumeni J F Jr, Hill J A. Neuroblastoma: epidemiologic approach to its origin. Am J Dis Child 1968; 115: 253-261.
8. Neglia J P, Smithson W A, Gunderson P. Prenatal and perinatal risk factors for neuroblastoma. Cancer 1988; 61: 2202-2206.
9. Sy W M, Edmonson J H. The developmental defects associated with neuroblastoma. Etiologic implications. Cancer 1968; 22: 234-238.
10. Shanklin D R, Sotelo-Avila C. In situ tumors in fetuses, newborns and young infants. Biol Neonat 1969; 14: 286-316.
11. Feingold M, Gheradi G J, Simons C. Familial neuroblastoma and trisomy 13. Am J Dis Child 1971; 121: 451.
12. Nevin N C, Dodge J A, Allen I V. Two cases of trisomy D associated with adrenal tumours. J Med Genet 1971; 9: 119-122.
13. Robinson M G, McCorquodale M M. Trisomy 18 and neurogenic neoplasia. J Pediatr 1981; 99: 428-429.
14. Powers L W, Register M K. Down syndrome and acute leukemia: epidemiological and genetic relationships. Lab Med 1991; 22: 630-636.
15. Dexeus F H, Logothetis C J, Chong C, Sella A, Ogden S. Genetic abnormalities in men with germ cell tumors. J Urol 1988; 140: 80-84.
16. Mann J R, Pearson D, Barrett A, Raafat F, Barnes J M, Wallendszus K R. Results of the United Kingdom children's cancer study group's malignant germ cell tumor studies. Cancer 1989; 63: 1657-1667.
17. Satge D, Jacobsen G K, Cessot F, Raffi F, Vekemans M. A fetus with Down Syndrome and intratubular germ cell neoplasia. Pediat Pathol 1995 (in press).
18. Barber R, Spiers P. Oxford survey of childhood cancers; progress report. II. Monthly Bull Minist Health London 1964; 23: 46-52.
19. Scholl T, Stein Z, Hansen H. Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Develop Med Child Neurol 1982; 24: 817-829.
20. Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. C R Acad Sci (Paris) 1959; 248: 1721-1722.
21. Delabar JM, Theophile D, Rahmani Z et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1993; 1: 114-124.
22. Korenberg J R, Chen X N, Schipper R et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 1994; 91: 4997-5001.
23. Anneren G, Edman B. Down syndrome. A gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene. Acta Pathol Microbiol Immunol Scand 1993; 101 suppl 40: 71-79.
24. Howard C M, Davies G E, Farrer M J et al. Meiotic crossingover on nondisjoined chromosomes of children with trisomy 21 and a congenital heart defect. Am J Hum Genet 1993; 53: 462-471.
25. Donato R. S-100 proteins. Cell Calcium 1986; 7: 123-145.
26. Donato R. Perspectives in S-100 protein biology. Cell Calcium 1991; 12: 713-726.
27. Winningham-Major F, Staecker J L, Barger S W, Coats S, van Eldik L J. Neunte extension and neuronal survival activities of recombinant S-100 beta proteins that differ in the content and position of cysteine residues. J Cell Biol 1989; 109: 3063-3071.
28. Azmitia E C, Dolan K, Whitaker-Azmitia P M. S-100 b but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res 1990; 516: 354-356.
29. Selinfreund R H, Barger S W, Pledger W J, van Eldik L J. Neurotrophic protein S-100 beta stimulates glial cell proliferation. Proc Natl Acad Sci USA 1991; 88: 3554-3558.
30. Allore R, O'Hanlon D, Price R et al. Gene encoding the beta subunit of S-100 protein is on chromosome 21: implications for Down syndrome. Science 1988; 239: 1311-1313.
31. Kato K, Suzuki F, Kurobe N et al. Enhancement of S-100 beta protein in blood of patients with Down's syndrome. J Mol Neurosci 1990; 2: 109-113.
32. Michetti F, Larocca L M, Rinelli A, Lauriola L. Immunocytochemical distribution of S-100 protein in patients with Down's syndrome. Acta Neuropathol 1990; 80: 475-478.
33. Griffin W S T, Stanley L C, Ling C et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 7611-7615.
34. Mito T, Becker L E. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome. Exp Neurol 1993; 120: 170-176.
35. Hachitanda Y, Nakagawara A, Nagoshi M, Tsuneyoshi M. Prognostic value of N-myc oncogene amplification and S-100 protein positivity in children with neuroblastic tumors. Acta Pathol Jpn 1992; 42: 639-644.
36. Shimada H, Aoyama C, Chiba T, Newton W A. Prognostic subgroups for undifferentiated neuroblastoma: immunohistochemical study with anti-S-100 protein antibody. Hum Pathol 1985; 16: 471-476.
37. Nagoshi M, Tsuneyoshi M, Enjoji M. S-100 positive undifferentiated neuroblastomas with a special reference to the tumor stroma related to favorable prognosis. Path Res Pract 1992; 188: 273-283.
38. Katsetos C D, Karkavelas G, Frankfurter A et al. The stromal Schwann cell during maturation of peripheral neuroblastomas. Clin Neuropathol 1994; 13: 171-180.
39. Biedler J L, Spengler B A. A novel chromosome abnormality in human neuroblastoma and antifolate-resistant chinese hamster cell lines in culture. J Natl Cancer Inst 1976; 57: 683-689.
40. Biedler J L, Helson L, Spengler B A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973; 33: 2643-2649.
41. Raju N R, Koestner A, Marushige K, Lovell K L, Okazaki D. Effect of nerve growth factor on the transplacental induction of neurinomas by ethylnitrosourea in Sprague-Dawley rats. Cancer Res 1989; 49: 7120-7123.
42. Marshak D R, Pena L A. Potential role of S-100 beta in Alzheimer's disease: an hypothesis involving mitotic protein kinases. In: Nadel L, Epstein C J, eds. Down Syndrome and Alzheimer Disease. New York: Wiley-Liss, 1992: 289-307.
43. Fano G, Mariggio M A, Angelella P et al. The S-100 protein causes an increase of intra cellular calcium and death of PC 12 cells. Neuroscience 1993; 53: 919-925.
44. Nakazato Y, Langing B H. Reduced number of neurons in esophageal plexus ganglia in Down syndrome: additional evidence for reduced cell number as a basic feature of the disorder. Pediatr Pathol 1986; 5: 55-63.
45. Russel B G, Kjaer I. Tooth agenesis in Down Syndrome. Am J Med Genet 1995; 55: 466-471.
46. Gordon M B. Morphological changes in the endocrine glands in mongolian idiocy with report of two cases. Endocrinology 1930; 14: 1-6.
47. Israel M A. Disordered differentiation as a target for novel approaches to the treatment of neuroblastoma. Cancer 1993; 71: 3310-3313.